Lactose Monohydrate, Rivaroxaban

• Pulmonary Embolism & Anticoagulation Evaluation in Cancer Patient - PEACE Pending
  2025-524110-28-00 Phase IV 1 country Region Hovedstaden
• Assessing the Efficacy of a Single Measurement and Adjustment Strategy for DOACs in Frail Older Patients. Recruiting
  2025-521362-10-00 Phase III/IV 1 country Academisch Ziekenhuis Maastricht
• Restarting Early versus Later Anticoagulation for Chronic Subdural Hematoma with Atrial Fibrillation (RELACS) Recruiting
  2025-521179-29-00 Phase II/III 2 countries HUS-Yhtymae
• Continuing Anticoagulants and Antiplatelets in Cold snare Polypectomy. Recruiting
  2024-511265-11-01 Phase IV 1 country Fundacion Instituto De Investigacion Sanitaria Aragon
• Short-term interruption versus continuous anticoagulation in colorectal polypectomy. A randomized multicenter investigator-initiated non-inf… Recruiting
  2024-512194-27-01 Phase IV 1 country Hospital Universitario Ramon Y Cajal
• Phase 3 study to assess the efficacy and safety of Givinostat versus hydroxyurea in Polycythemia Vera patients Recruiting
  2022-502276-23-00 Phase III 11 countries Italfarmaco S.p.A.
• Anticoagulant Regimens Given to achieve thrombus regression and reduce clinical Outcomes among patients with Non device-related intra-cardia… Ended
  2024-512685-33-00 Phase III 1 country Centre Hospitalier Universitaire De Nimes
• GENPAD Ended
  2024-518122-33-00 Phase IV 1 country Radboud universitair medisch centrum Stichting
• SHORT RUN AF "Rivaroxaban versus standard of care for patients with excessive atrial ectopy or short atrial runs and high embolism risk" Ended
  2024-516374-29-00 Phase III/IV 1 country Assistance Publique Hopitaux De Paris
• A trial to learn if andexanet alfa is safe and works to limit bleeding in people who take factor 10a inhibitors and urgently need surgery Ended
  2022-501353-37-00 Phase III 19 countries Astrazeneca AB

Showing 1–10 of 10 trials